May 24, 2019

Published: May 24, 2019
Category:
Canadian Cancer Trials Group investigator Janet Dancey, Chris O'Callaghan, Wendy Parulekar

For the scientists at CCTG, their inspiration comes from the people their questions are designed to help: patients living with cancer.

“These people are at their most vulnerable,” says Dr. Dancey. “When they enroll in a trial, they do it because they hope to get the best treatment. But they also do it to help answer an important question, if not for themselves, then for everyone who follows them. For me, these people are heroes. In the face of adversity, they act for the greater good.”

Read More

Published: May 24, 2019
Category:
Precision medicine targeting each individuals unique form of cancer

Today we think about cancer in terms of the tumour site—breast, lung, colon, brain, each is separate with different treatments. Precision medicine is a new way of looking at cancer. Instead of focusing on the site of the cancer, it identifies the genetic abnormalities that make cancer possible in individual patients.  

Read More

Published: May 24, 2019
Category:

Once the initial shock of a cancer diagnosis wears off, patients and families are left with questions. Lots and lots of questions. It might come as a relief to know that some of the most brilliant, accomplished scientists from around the world are listening.  

“The biggest question we ask is the one that all cancer patients have,” says CCTG Scientific Director Dr. Janet Dancey. “What is the best treatment?”

Read More

Published: May 24, 2019
Category:
https://www.ctg.queensu.ca/cctg_news/2019-new-investigator-clinical-trials-course

2019 New Investigator Clinical Trials Course

Mark your calendars for the next CCTG New Investigator Clinical Trials Course (NICTC) being held August 7th to the 9th at the Donald Gordon Centre in Kingston, Ontario.

The NICTC is an important component of the group mandate to provide and facilitate investigator education and training. The major goal of this three-day course is to familiarize new investigators from across the country with the essentials of clinical trial conduct in the Canadian research environment.

Read More

May 23, 2019

Published: May 23, 2019
Category:
New Investigator Clinical Trials Course

New Investigator Clinical Trials Course

Mark your calendars for the next CCTG New Investigator Clinical Trials Course (NICTC) being held August 7th to the 9th at the Donald Gordon Centre in Kingston, Ontario.

Read More

May 15, 2019

Published: May 15, 2019
Category: Trials

CCTG HNC2 (NRG HN004) - Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin Has now been centrally activated in Canada, the trial is being led by NRG Oncology in the US, and CCTG is sponsor in Canada.

Read More

Published: May 15, 2019
Category: Group updates
claiming CME credits

CCTG Spring meeting travel expenses are reimbursed only by submitting a properly completed travel expense claim form. This form, accompanied by original documents, should be submitted to CCTG Group Administrator’s Office no later than 30 June 2019. 

Read More

In recognition of the critical role played by the CCTG throughout her professional career, Dr. Frances Shepherd has provided support for an annual travel award to recognize excellence in clinical trials and translational research within CCTG research projects.

Read More